Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Lipari Mining and SpurChain Partner to Tokenize Natural Diamond Production (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Biosyent Inc
V.RX
Alternate Symbol(s):
BIOYF
Healthcare
Biotechnology
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., sources, acquires or in-licenses and further develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary, operates the Company’s...
business marketing biologically and health friendly non-chemical insecticides. The Company’s products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia. FeraMAX Pd Maintenance 45 is a chewable supplement with iron plus vitamin B12 and vitamin C for the prevention of iron deficiency anemia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(63)
•••
colourama
X
Comment by
colourama
on Nov 06, 2025 7:53pm
RE:RE:Pretty Spectacular Quarter, Stock is insanely cheap 10x EPS
Some weakness here... looks like a good place to add!
(63)
•••
colourama
X
Comment by
colourama
on Sep 06, 2025 9:33am
RE:Combogesic:
prophetoffactz, I know your comment is highlighting potential for combogesic, but I just want to put out there that there is no evidence suggesting Tylenol use during pregnancy increases autism risk
...more
(266)
•••
prophetoffactz
X
Post by
prophetoffactz
on Sep 05, 2025 3:26pm
Combogesic:
@CNBC · 58m Kenvue stock drops 10% on report
...more
(63)
•••
colourama
X
Post by
colourama
on Aug 22, 2025 11:38am
Another great quarter, with Q3 looking strong
Continued great results! And Rene commenting that the momentum has continued into Q3. I saw in the MD&A that in July they shipped a $0.6 million Feramax international order, which should
...more
(63)
•••
colourama
X
Comment by
colourama
on Aug 12, 2025 4:37pm
RE:Pretty Spectacular Quarter, Stock is insanely cheap 10x EPS
Stock largely asleep in summer lull... what do we expect for the next quarter?
(37)
•••
FormerHedgie
X
Post by
FormerHedgie
on May 15, 2025 6:24pm
Pretty Spectacular Quarter, Stock is insanely cheap 10x EPS
Pretty spectacular quarter from RX. Revenue up 42% y-y, 45% EBITDA grwoth an 31% Net Income Growth. The market cap is 125M and ther is $25M in net cash now debt For Revenue / EBITDA / EPS
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 14, 2025 5:30pm
New Press Release - BioSyent to Attend Planet MicroCap Showcase
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April 24th, 2025 at the Paris Hotel & Casino...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 04, 2025 5:01pm
New Press Release - BioSyent to Present at LD Micro New York Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 4, 2025) - BioSyent Inc. (TSXV: RX) ("BioSyent" or the "Company") announces that Mr. René Goehrum, President and CEO of BioSyent, will be presenting in person at the LD Micro Invitational XV Conference in New York City on Thursday, April 10th at 12...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 01, 2025 8:00am
New Press Release - FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year
MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians(1). This year marks the tenth...
read article.
(37)
•••
FormerHedgie
X
Comment by
FormerHedgie
on Mar 25, 2025 12:18pm
RE:RE:RE:RE:RE:Think the endocrine drug is Zofenopril | high blood pressure
Thanks for the information. The health Canada filing by RX for zofenopril is still there as well then. Perhaps there will be 2 new products coming to market. The more the better
...more
(23)
•••
FinnishFlash8
X
Comment by
FinnishFlash8
on Mar 23, 2025 9:38am
RE:RE:RE:RE:Think the endocrine drug is Zofenopril | high blood pressure
Ren, sorry
(23)
•••
FinnishFlash8
X
Comment by
FinnishFlash8
on Mar 23, 2025 9:37am
RE:RE:RE:Think the endocrine drug is Zofenopril | high blood pressure
First of all, Zofenopril is a cardiovascular drug, not an endocrine drug. Secondly, Ren said the following in the Q4 2024 results presentation on March 13, 2025: “In June, we
...more
(1601)
•••
Possibleidiot01
X
Comment by
Possibleidiot01
on Mar 15, 2025 9:06pm
RE:Mathieu Martin - Stocks and Stones
Left out the heading What I'm Keeping or Adding To
(1601)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Mar 15, 2025 9:01pm
Mathieu Martin - Stocks and Stones
https://stocksandstones.substack.com/p/how-to-navigate-tariffs Canadian companies selling in Canada. Canadian companies selling domestically should do well if protectionist measures are
...more
(37)
•••
FormerHedgie
X
Post by
FormerHedgie
on Mar 14, 2025 9:27am
Very nice quarter / year end, stock should be 50% higher!!!
Very nice quarter / year end from RX. They maintained their profitability and growth while continuing to invest in new products. It looks like Q4 may have shown some early signs of their
...more
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >